Home / Insight / Artificial Intelligence

Artificial Intelligence

Back to Artificial Intelligence

Welcome to our Artificial Intelligence CMS Insights section, which provides some hot topics from CMS about artificial intelligence (AI).

AI opportunities and risks

AI is opening up transformational opportunities in all areas of human activity, but at the same time poses unique risks for companies, governments and society as a whole. These opportunities and legal risks present a wide range of ethical, legal and regulatory challenges. The scope, speed and nature of the response to these challenges, will have a significant impact on the success of AI in contributing to prosperity in a manner that balances human well-being and economic growth.

Questions related to AI

There are many questions that relate to AI including what is artificial intelligence? What is the future of AI? How can AI be used? Are there any limitations to AI innovation? Could AI be used for modelling credit risk and who legally owns the intellectual property rights for something created by AI? Artificial intelligence from a legal perspective includes interesting debates about who is at fault if AI systems fail or cause damage, there is a question of liability for the results of AI decision making and reasoning.

CMS - the first choice for all legal services related to AI and technology 

At CMS we are keen to stimulate the AI legal debate and to help provide guidance to our clients. CMS has a long history of advising companies large and small to leverage the benefits of new technology whilst limiting the possible legal risks. CMS as a future facing law firm is regarded by many companies as their first choice for all legal services related to AI and legal technology advice. To find out more about our expertise in Technology, Media & Telecommunications and how we can help please visit our dedicated section about TMT - Technology, Media & Telecommunications.


Show only
10 OCtober 2019
AI and data min­ing – ques­tions of copy­right
2 October 2019
AI and per­son­al­ised medi­cine
24 September 2019
AI in dia­gnos­is – pat­ent pro­tec­tion
19 September 2019
AI & pa­tient com­pli­ance
17 September 2019
Us­ing AI for Drug Dis­cov­ery – IP con­sid­er­a­tions